There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific community: the need to phase out animal testing in biomedical research.
The new leaders of both the National Institutes of Health and the Food and Drug Administration have said they plan to reduce their use in federally funded research, continuing an effort started in the Biden administration.
Technology is helping bring about change with advances that allow scientists to create structures from human cells that can mimic our organs. In some contexts, those cells work better for studying diseases and drug side effects than traditional experiments that lead to the deaths of millions of rodents, dogs and primates every year.
